NORD Says Orphan Drug Act Is Fine As Is, Wants To Work For Improvements Within System

The group is afraid asking for wholesale changes to the law would invite too many problems, VP Dorman says at BIO.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet